Feras M Ghazawi Selected Research

Psoriasis (Pustulosis Palmaris et Plantaris)

1/2021

A Review of the Efficacy and Safety for Biologic Agents Targeting IL-23 in Treating Psoriasis With the Focus on Tildrakizumab.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Feras M Ghazawi Research Topics

Disease

3	Neoplasms (Cancer) 12/2018 - 12/2006
2	Infections 01/2024 - 09/2020
2	Carcinoma (Carcinomatosis) 01/2024 - 01/2021
2	COVID-19 01/2024 - 09/2020
2	Pemphigus (Pemphigus Vulgaris) 01/2024 - 09/2019
2	Skin Diseases (Skin Disease) 01/2024 - 09/2020
2	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 01/2023 - 07/2020
1	Cutaneous Leishmaniasis 01/2024
1	Actinic Keratosis 01/2024
1	Actinic cheilitis 01/2024
1	Procedural Pain 01/2024
1	Acne Vulgaris 01/2024
1	Bowen's Disease (Disease, Bowen) 01/2024
1	Basal Cell Carcinoma (Rodent Ulcer) 01/2024
1	Folliculitis (Sycosis) 01/2024
1	Mycosis Fungoides 01/2024
1	Extramammary Paget Disease (Paget Disease, Extramammary) 01/2024
1	Skin Neoplasms (Skin Cancer) 01/2024
1	Onychomycosis (Tinea Unguium) 01/2024
1	Lichen Sclerosus et Atrophicus (Lichen Sclerosus) 01/2024
1	Brain Neoplasms (Brain Tumor) 01/2023
1	Cicatrix (Scar) 01/2023
1	Primary Hypertrophic Osteoarthropathy (Hypertrophic Osteoarthropathy, Primary) 09/2021
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2021
1	Atopic Dermatitis (Atopic Eczema) 01/2021
1	Virus Diseases (Viral Diseases) 09/2020
1	Acute Generalized Exanthematous Pustulosis 05/2020
1	Pachyonychia Congenita (Jadassohn-Lewandowsky Syndrome) 02/2019
1	Hidradenitis Suppurativa 01/2019
1	Leg Ulcer 01/2019
1	Genomic Instability 12/2018
1	Chromosomal Instability (Chromosome Stability) 12/2018
1	HIV Infections (HIV Infection) 08/2013
1	Carcinogenesis 12/2006

Drug/Important Bio-Agent (IBA)

2	AntigensIBA 01/2024 - 01/2023
2	CytokinesIBA 01/2023 - 09/2020
2	Interleukin-23 (Interleukin 23)IBA 01/2021 - 09/2020
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2024
1	Prednisone (Sone)FDA LinkGeneric 01/2024
1	Particulate MatterIBA 01/2023
1	EicosanoidsIBA 09/2021
1	Janus Kinase InhibitorsIBA 01/2021
1	Interleukin-13 Receptors (Interleukin 13 Receptor)IBA 01/2021
1	tildrakizumabIBA 01/2021
1	Interleukin-17 (Interleukin 17)IBA 09/2020
1	Interleukin-12 (IL 12)IBA 09/2020
1	Immunoglobulin E (IgE)IBA 09/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 07/2020
1	Morphine (MS Contin)FDA LinkGeneric 05/2020
1	Adrenal Cortex Hormones (Corticosteroids)IBA 09/2019
1	Keratin-17 (Keratin 17)IBA 02/2019
1	desomorphineIBA 01/2019
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019
1	Proteins (Proteins, Gene)FDA Link 12/2018
1	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 12/2018
1	DNA (Deoxyribonucleic Acid)IBA 12/2018
1	Biomarkers (Surrogate Marker)IBA 08/2013
1	Butyrates (Butyrate)IBA 12/2006
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 12/2006
1	Histone Deacetylase InhibitorsIBA 12/2006
1	Valproic Acid (Depakote)FDA LinkGeneric 12/2006

Therapy/Procedure

4	Therapeutics 01/2024 - 11/2017
2	Immunotherapy 09/2020 - 12/2018
1	Photochemotherapy (Photodynamic Therapy) 01/2024
1	Chemoprevention 01/2024
1	Radiotherapy 01/2023
1	Secondary Prevention 01/2021
1	Biological Therapy 01/2021